Dramatic increase in parathyroid hormone and hypocalcaemia after denosumab in a kidney transplanted patient

ISSN： 2048-8505

Source： Clinical Kidney Journal, Vol.6, Iss.1, 2013-02, pp. : 122-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Impact of Treatments for Postmenopausal Osteoporosis (Bisphosphonates, Parathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review

By Gallacher S.

Calcified Tissue International, Vol. 87, Iss. 6, 2010-12 ,pp. : 469-484

Springer Publishing Company

Access to resources Recommend Favorite

Treatment with Parathyroid Hormone hPTH(1-34), hPTH(1-31), and Monocyclic hPTH(1-31) Enhances Fracture Strength and Callus Amount After Withdrawal Fracture Strength and Callus Mechanical Quality Continue to Increase

By Andreassen T. T. Willick G. E. Morley P. Whitfield J. F.

Calcified Tissue International, Vol. 74, Iss. 4, 2004-04 ,pp. : 351-356

Springer Publishing Company

Access to resources Recommend Favorite

Parathyroid hormone expression in a patient with metastatic nasopharyngeal rhabdomyosarcoma and hypercalcemia

By Wong Katy Tsuda Shawn Mukai Ryan Sumida Kenneth Arakaki Richard

Endocrine Journal, Vol. 27, Iss. 1, 2005-06 ,pp. : 83-86

Humana Press, Inc

Access to resources Recommend Favorite

Parathyroid Hormone and Bone Healing

By Ellegaard M.

Calcified Tissue International, Vol. 87, Iss. 1, 2010-07 ,pp. : 1-13

Springer Publishing Company

Access to resources Recommend Favorite

Postoperative Care of the Transplanted Patient

Current Cardiology Reviews, Vol. 7, Iss. 2, 2011-05 ,pp. : 110-122

Bentham Science Publishers

Access to resources Recommend Favorite